Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Rein Therapeutics (RNTX) Return on Assets (2017 - 2025)

Rein Therapeutics (RNTX) has disclosed Return on Assets for 9 consecutive years, with 0.27% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 51.0% to 0.27% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.27% through Dec 2025, up 51.0% year-over-year, with the annual reading at 0.23% for FY2025, 54.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.27% at Rein Therapeutics, up from 1.09% in the prior quarter.
  • The five-year high for Return on Assets was 0.18% in Q1 2024, with the low at 1.23% in Q1 2023.
  • Average Return on Assets over 5 years is 0.7%, with a median of 0.71% recorded in 2024.
  • The sharpest move saw Return on Assets skyrocketed 105bps in 2024, then plummeted -88bps in 2025.
  • Over 5 years, Return on Assets stood at 0.51% in 2021, then tumbled by -117bps to 1.12% in 2022, then soared by 76bps to 0.27% in 2023, then crashed by -191bps to 0.78% in 2024, then surged by 65bps to 0.27% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.27%, 1.09%, and 1.07% for Q4 2025, Q3 2025, and Q2 2025 respectively.